InvestorsHub Logo

Cats83

02/19/14 4:41 PM

#15795 RE: markjohn62 #15794

Thanks for sharing that info straight from the CEO! Welcome aboard and things are getting exciting here for all involved.

Bsav88atty

02/19/14 8:11 PM

#15800 RE: markjohn62 #15794

Hey there, markjohn. Many thanks for sharing! Are you the same fella over on the YMB? You also have a little $ATRS as well, correct? Sorry if I've missed your posts on iHub in the past, but a belated welcome.

coolerheadsprevail

02/20/14 2:22 AM

#15811 RE: markjohn62 #15794

Q's for Bob S.


In the company Q/A it seems to indicate Rapimeds approval was going to be for Mainland China rather than Hong Kong. Does this mean You have yet to apply in China?

Hong Kong was first as it is the gold standard in China. Once approved there getting the rest of China becomes a much simpler process.


If not, will it require a 90 day review period?

No not that long since approval in HK has been accomplished


If you have not, when do you anticipate filing?

As soon as the packaging is translated into simple Chinese


Is Rapimeds still possible for U.S. Q2 launch?

We want to get China buttoned up first


Do you have an estimate on possible Class 2 DEA license timeline.

30 days or less in TN


@markjohn62,
Where did you get this info from? It appears to be either an excerpt from an email or an excerpt from a Q&A type of document, but I did not notice any updates to the Q&A on the SCRC website.

I would hope that Bob updates the Q&A to reflect this in order to put SCRC's official stamp on these statements. It is very reminiscent of the other poster who claimed to be on the team working on registering RapiMeds in HK and China -- and extremely unorthodox for a public company to be making not only forward looking statements but also providing timelines for expected catalysts (such as expected licensure for a Class 2 DEA license) to specific individuals and not to the market at-large via official company PR (or at least other official company medium such as its website).